CompoAtlas

Digestive Enzymes and Betaine Hal

Food supplement declared in France, declaration No 2024-2-1239, decision dated 20 February 2024

Digestive Enzymes and Betaine Hal (Igennus) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Bétaïne, Protéase, Papaïne, Bromélaïne, Lipase. None of the rules we check flags an issue with its declared composition.

Brand
Igennus
Food business operator placing the product on the market
Igennus
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
1 capsule
Directions for use
Avaler
Intended populations
Men, Women
Not recommended (according to the manufacturer)
Adolescents (under 18), Children (under 12), Young children (aged 1 to 3), Ulcer (stomach or duodenum), Children (under 6), Children (under 10)
Objectives stated by the manufacturer (these are not authorised claims)
Digestion
Flavourings
Nul

Declaration 139311, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Other active ingredients

NamePer day
Bétaïnenot declared
Protéasenot declared
Papaïnenot declared
Bromélaïnenot declared
Lipasenot declared
Amylasenot declared
Glucoamylasenot declared
Lactasenot declared
Cellulasenot declared
Alpha-galactosidasenot declared

Additives

E464

Other ingredients

Extrait de riz

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Consultez un médecin professionnel avant de prendre ce complément alimentaire si vous êtes enceinte ou si vous allaitez, si vous souffrez d'un problème de santé (notamment ulcère gastroduodénal ou duodénal) ou si vous prenez des médicaments. Ne retirez pas la poudre de l’enveloppe de la capsule. Arrêtez l'utilisation si vous ressentez des maux d'estomac.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Bétaïne
    Read the warning, when it applies and the studies cited

    BETAINE / BETAINE HYDROCHLORIDE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Applies to products containing Betaine hydrochloride (as a medicinal ingredient or as a source ingredient).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a peptic ulcer or excess stomach acid (RSC 2024; Hendler and Rorvik 2008).

    Sources cited by Health Canada (2)
    • Hendler SS, Rorvik DM. PDR® for Nutritional Supplements, 2nd edition. Thomson Reuters. Physicians' Desk References Inc., NJ; 2008.
    • RSC 2024: Royal Society of Chemistry: The Merck Index Online [Accessed 2024 June 20]. Available from: https://merckindex.rsc.org/

    Applies to products providing 600 milligrams or more of Betaine or 780 milligrams or more of Betaine hydrochloride as a medicinal ingredient, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have high cholesterol (Olthof et al. 2005; Swab et al. 2002).

    Sources cited by Health Canada (2)
    • Olthof MR, van Vliet T, Verhoef P, Zock PL, Katan MB. Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in health humans. PLoS Medicine 2005;2(5):e135. PubMed Randomised trial
    • Swab U, Torronen A, Toppinen L, Alfthan G, Saarinen M, Aro A, Uusitupa M. Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. American Journal of Clinical Nutrition 2002;76:961-967.

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Igennus

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Digestive Enzymes and Betaine Hal (Igennus): composition and regulation”, https://compoatlas.com/en/supplements/products/139311-digestive-enzymes-and-betaine-hal, updated 15 November 2026.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line